Drug
Torsemide clinical trials
Also written Torasemide.
- studies test it
- 23
- open now
- 3
- in phase 3
- 5
- first study started
- 2001
Keep track of what changes. Save the Torsemide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
23 studies that test it; most in 2021 (5)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 5 |
| 2023 | 1 |
| 2025 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 1
- Phase 3
- 5
- Phase 4
- 7
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 12
Sarfez Pharmaceuticals, Inc. (4) · Roxane Laboratories (2) · Par Pharmaceutical, Inc. (2) · Duke University (1) · Yale University (1) · Ospedale San Raffaele (1) · NHS Greater Glasgow and Clyde (1) · Pharmtechnology LLC (1)
Often tested with
Tested in the same studies.
Spironolactone (4) · Furosemide (3) · Codeine (2) · Midazolam (2) · Pravastatin (2) · Talinolol (2) · Tolvaptan (1) · Empagliflozin (1)
Studies
Open first, then newest update. How each study uses Torsemide is read from its arms, and is right about nine times in ten.
Testing it · 23
- A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:RecruitingPhase 1Berlin-Chemie AG Menarini GroupNCT07201584Written as Torasemide tablet 10 mg
- Optimal Medical Treatment of Difficult-to-treat HypertensionRecruitingPhase 4National Institute of Cardiology, Warsaw, PolandNCT06275763Written as Phase C: Torasemide
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingPhase 4Heart Center Research, LLCNCT06218199Written as Torsemide
- A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 HrsWithdrawnPhase 4Sarfez Pharmaceuticals, Inc.NCT06708611Written as torsemide
- Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg FurosemideTerminatedPhase 1Sarfez Pharmaceuticals, Inc.NCT03509545Written as CHF Patients: ER Torsemide 40 mg
- Bioavailability and Bioequivalence Study of Extended Release Torsemide and SpironolactoneCompletedPhase 3Sarfez Pharmaceuticals, Inc.NCT07046975Written as Torsemide and Spironolactone tablet
- Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy SubjectsCompletedPhase 3Sarfez Pharmaceuticals, Inc.NCT07015671Written as 10 mg Torsemide tablet
- TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureCompletedPhase 3Duke UniversityNCT03296813Written as Torsemide
- Torsemide Comparison With Furosemide for Management of Patients With Stable Heart FailureCompletedPhase 3Yale UniversityNCT05093621Written as Torsemide
- Pharmacogenetics of Torasemide and Spironolactone in Hypertension TreatmentCompletedPhase 3Ospedale San RaffaeleNCT06413082Written as Torasemide
- Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in HypertensionCompletedPhase 4NHS Greater Glasgow and ClydeNCT03354897Written as Torasemide 5Mg Tablet
- Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting ConditionsCompletedPhase 1Pharmtechnology LLCNCT04921566Written as Torasemide tablet 10 mg
- Weight-Based Torsemide Dosing in Subjects With Heart FailureCompletedPhase 4New York City Health and Hospitals CorporationNCT03187509Written as Torsemide
- ToRsemide for pOstpartum HYpertensionCompletedPhase 2The University of Texas Health Science Center, HoustonNCT02813551Written as Torsemide
- Bioequivalency Study of Torsemide Tablets Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00602303Written as Torsemide
- Bioequivalency Study of Torsemide Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00602615Written as Torsemide
- The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart FailureStatus unknownPhase 4Medical University of WarsawNCT01942109Written as Torasemide
- The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves ReplacementCompletedPhase 4Shanghai Chest HospitalNCT02644616Written as tolvaptan+torasemide
- Open Label Study for the Functional Characterization of Drug Metabolism and TransportCompletedPhase 1Matthias SchwabNCT01788254Written as torsemide
- Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 DiabetesCompletedPhase 1Boehringer IngelheimNCT01276288Written as torasemide
See all 23 studies that test Torsemide →
Given in every arm · 1 — Torsemide is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Torsemide
- A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)TerminatedPhase 1Merck Sharp & Dohme LLCNCT01558674Written as Torsemide
- Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy SubjectsCompletedPhase 1Sarfez Pharmaceuticals, Inc.NCT03214874Written as Demadex 20mg Tablet
- Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.Status unknownPhase 4Society of Specialists in Heart FailureNCT02087332Written as Torasemide (Diuver)
Codes
What other systems call Torsemide · ClinicalTrials.gg INT006809
- MeSH (NLM) D000077786TorsemideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) W31X2H97FBTORSEMIDEConfirmed FDA, NLM
- RxNorm 38413One source FDA
- NCI Thesaurus C29506TorsemideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077786 | Torsemide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | W31X2H97FB | TORSEMIDE | Confirmed FDA, NLM |
| RxNorm | 38413 | — | One source FDA |
| NCI Thesaurus | C29506 | Torsemide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.